Literature DB >> 18727972

Saphenous vein graft aneurysm with graft-enteric fistula after renal artery bypass.

Mark M Levy1, William Kiang, Jason M Johnson, Stuart I Myers.   

Abstract

A 65-year-old female presented with upper gastrointestinal hemorrhage thirty years following an aorta-to-right renal artery bypass constructed with saphenous vein. Upper endoscopy demonstrated a duodenal ulcer, and a CAT scan demonstrated aneurysmal degeneration of her renal artery bypass with duodenal impingement. Laparotomy demonstrated erosion of the aneurysm through the posterior wall of the duodenum; extra-anatomic renovascular reconstruction and primary duodenal repair was performed. Although aneurysmal degeneration of intraabdominal saphenous vein grafts is well described and rupture likewise reported, this report represents the first description of an intraabdominal autogenous vein graft aneurysm presenting with gastrointestinal erosion and fistula.

Entities:  

Mesh:

Year:  2008        PMID: 18727972     DOI: 10.1016/j.jvs.2008.03.045

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

Review 1.  Enteric fistulation after renal artery reconstruction: a systematic literature review.

Authors:  David Bergqvist; Martin Björck
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

2.  The use of polytetrafluoroethylene graft for damaged renal artery in ABO-incompatible living donor kidney transplantation: a case report.

Authors:  Won-Bae Chang; Young-Heun Shin; Hyung Sub Park; Dong-Hwan Kim; Taeseung Lee
Journal:  Korean J Transplant       Date:  2022-03-31

3.  Arterial reconstruction using the donor's gonadal vein in living renal transplantation with multiple renal arteries: a case report and a literature review.

Authors:  Mitsuru Tomizawa; Shunta Hori; Nobutaka Nishimura; Chihiro Omori; Yasushi Nakai; Makito Miyake; Tatsuo Yoneda; Kiyohide Fujimoto
Journal:  BMC Nephrol       Date:  2020-05-20       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.